| Product Code: ETC8534490 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Cell and Gene Therapy Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Cell and Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Cell and Gene Therapy Market - Industry Life Cycle |
3.4 Netherlands Cell and Gene Therapy Market - Porter's Five Forces |
3.5 Netherlands Cell and Gene Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Netherlands Cell and Gene Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Netherlands Cell and Gene Therapy Market Revenues & Volume Share, By Delivery Mode, 2021 & 2031F |
3.8 Netherlands Cell and Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Netherlands Cell and Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and funding for cell and gene therapy research and development in the Netherlands |
4.2.2 Growing prevalence of genetic disorders and chronic diseases driving the demand for advanced treatment options |
4.2.3 Technological advancements in cell and gene therapy leading to improved efficacy and safety of treatments |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy treatments limiting accessibility for a wider patient population |
4.3.2 Regulatory challenges and stringent approval processes for cell and gene therapy products |
4.3.3 Limited awareness and understanding of cell and gene therapy among healthcare professionals and patients |
5 Netherlands Cell and Gene Therapy Market Trends |
6 Netherlands Cell and Gene Therapy Market, By Types |
6.1 Netherlands Cell and Gene Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 Netherlands Cell and Gene Therapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.3 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Oncology Disorder, 2021- 2031F |
6.2.4 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Genetic Disorder, 2021- 2031F |
6.2.5 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.2.6 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Neurological Disorder, 2021- 2031F |
6.2.7 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Cell and Gene Therapy Market, By Delivery Mode |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Cell and Gene Therapy Market Revenues & Volume, By In-Vivo, 2021- 2031F |
6.3.3 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Ex-Vivo, 2021- 2031F |
6.4 Netherlands Cell and Gene Therapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Cancer Care Centers, 2021- 2031F |
6.4.4 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.5 Netherlands Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Cell and Gene Therapy Market Import-Export Trade Statistics |
7.1 Netherlands Cell and Gene Therapy Market Export to Major Countries |
7.2 Netherlands Cell and Gene Therapy Market Imports from Major Countries |
8 Netherlands Cell and Gene Therapy Market Key Performance Indicators |
8.1 Patient outcomes and treatment efficacy measured through clinical trials and real-world data |
8.2 Adoption rate of cell and gene therapy treatments by healthcare facilities and providers |
8.3 Research and development investment in innovative technologies and therapies |
8.4 Number of partnerships and collaborations between academic institutions, biopharmaceutical companies, and research organizations in the field of cell and gene therapy |
9 Netherlands Cell and Gene Therapy Market - Opportunity Assessment |
9.1 Netherlands Cell and Gene Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Netherlands Cell and Gene Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Netherlands Cell and Gene Therapy Market Opportunity Assessment, By Delivery Mode, 2021 & 2031F |
9.4 Netherlands Cell and Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Cell and Gene Therapy Market - Competitive Landscape |
10.1 Netherlands Cell and Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Cell and Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here